Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles J. Homcy currently holds 31,113 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles J. Homcy has been a net seller of BBIO stock. They have purchased $0 and sold $51.9M worth of shares.
Charles J. Homcy's most recent insider trade was on Nov 19, 2025, when they sold 1,489 shares at $0.00 per share.
Charles J. Homcy serves as Executive at BridgeBio Pharma, Inc. (BBIO). They have executed 149 insider transactions totaling $51.9M over their tenure at the company.
Charles J. Homcy holds the position of Executive at BridgeBio Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Charles J. Homcy has shown a selling trading pattern, with $0 in total purchases and $51.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles J. Homcy was on Aug 8, 2025, when they sold $8.8M worth of BBIO shares. This transaction involved 191,662 shares at $45.87 per share.
Charles J. Homcy currently owns 31,113 shares of BridgeBio Pharma, Inc. (BBIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles J. Homcy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles J. Homcy has 149 Form 4 filings on record as an insider at BridgeBio Pharma, Inc..
Set alerts for Charles J. Homcy and 40,000+ other insiders.